Canadian Syncope Risk Score

Canadian Syncope Risk Score
Clinical Evaluation:
ED Diagnosis: Vasovagal Syncope
ED Diagnosis: Cardiac Syncope
Heart Disease History (any)
Any Predisposition to Vasovagal Symptoms (warm crowded place, prolonged standing, fear, emotion, pain)
Investigations:
Systolic BP <90 or >180 mmHg
Elevated Troponin (>99th percentile)
Abnormal QRS Axis (<-30° or >100°)
Corrected QT >480 ms
Shortness of Breath
Canadian Syncope Risk Score:0
Predicts 30-day serious adverse events in patients presenting with syncope.

Why Use

Syncope is a common, often benign presenting complaint in emergency departments, that sometimes has life-threatening underlying causes. The Canadian Syncope Risk Score identifies patients with syncope who are at higher risk of adverse outcomes. Can potentially avoid unnecessary investigation and/or admission.

When to Use

Patients ≥16 years old presenting ≤24 hours of syncope. Do not use in patients with any of the following: Prolonged (>5 min) LOC. Change in mental status from baseline. Obvious witnessed seizure. Major trauma requiring hospital admission. Intoxication with alcohol or illicit drugs. Language barrier. Head trauma causing LOC.

Formula

Addition of the selected points: Category Points Clinical evaluation Predisposition to vasovagal symptoms* -1 History of heart disease 1 Any systolic pressure reading <90 or >180 mmHg 2 Investigations Elevated troponin level (>99th percentile of normal population) 2 Abnormal QRS axis (<-30° or >100°) 1 QRS duration >130 ms 1 Corrected QT interval >480 ms 2 Diagnosis in emergency department ED diagnosis (based on ED evaluation) Vasovagal syncope -2 Cardiac syncope 2 Neither 0 *Triggered by being in a warm crowded place, prolonged standing, fear, emotion or pain.

Pearls / Pitfalls

Predicts risk of 30-day serious adverse events associated with syncope, defined as any of the following: death, arrhythmia, non-arrhythmic cardiac causes, or non-cardiac causes (see Evidence for full list). In 2020, the CSRS was successfully validated (see Evidence , below).

Advice

Patients at medium or high risk (≥1 point) should undergo further investigation for cardiac and non-cardiac causes of syncope.

More Information

Interpretation: Score Estimated risk of serious adverse event** Risk category -3 0.4% Very low -2 0.7% -1 1.2% Low 0 1.9% 1 3.1% Medium 2 5.1% 3 8.1% 4 12.9% High 5 19.7% 6 28.9% Very high 7 40.3% 8 52.8% 9 65.0% 10 75.5% 11 83.6% **Death, arrhythmia, myocardial infarction, serious structural heart disease, aortic dissection, pulmonary embolism, severe pulmonary hypertension, severe hemorrhage, subarachnoid hemorrhage, or any other serious condition causing syncope and procedural interventions for the treatment of syncope.

Oh hi there 👋
It’s nice to meet you.

New scoring tools, dose references, and guideline summaries straight to your inbox.

We don’t spam! Read our privacy policy for more info.

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *